EVIO (EVIO) PNK at $0.0001 on 19 Mar 2026: top gainer, volume 5,169,750

EVIO stock surged to $0.0001 in United States market hours on 19 Mar 2026, making it a top gainer on the PNK exchange. Trading volume reached 5,169,750 shares, well above the 355,847 average, driving a relative volume of 14.53. We view this move as short-term trader interest rather than a valuation turnaround. Meyka AI provides this AI-powered market analysis to explain drivers, risks, and where price momentum could head next.

Price action and volume spike

EVIO, Inc. (EVIO) closed at $0.0001 after an intraday high of $0.0001 and a low of $0.0000. Volume for the session hit 5,169,750.00, versus average volume 355,847.00, giving a relVolume of 14.53. This volume spike is the main catalyst for the top gainer status during market hours on 19 Mar 2026.

Business snapshot and sector context

EVIO, Inc. operates analytical testing and advisory services for the U.S. cannabis industry from Henderson, Nevada. The company is listed on the PNK exchange and reports in USD. The stock sits in the Healthcare sector under Drug Manufacturers – Specialty & Generic, a sector with mixed sentiment this quarter.

Key financials and valuation metrics

Market capitalization stands at 1,919,369.00 USD with shares outstanding 19,193,690,000.00. Trailing EPS is -0.27, and price to sales is 1.21. Enterprise value to sales reads 6.09, and the current ratio is a low 0.04, signalling liquidity pressure. These ratios show a microcap with thin liquidity and tight working capital.

Technical indicators and Meyka AI grade

Momentum shows neutral to positive short-term signs: RSI 54.80, ADX 50.25 indicates a strong short-term trend, and ROC is extreme at 9900.00% reflecting the penny-stock jump. Meyka AI rates EVIO with a score out of 100: 65.95 | Grade: B | Suggestion: HOLD. This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus.

Catalysts, risks and sector drivers

Catalysts include renewed retail interest and any regulatory clarity in cannabis testing standards. Major risks are poor liquidity, low book value per share (-0.01), negative operating cash flow per share -0.00, and high payables. Sector trends in cannabis testing and state-level rule changes will heavily influence EVIO’s near-term performance.

Trading outlook and Meyka AI forecast

Meyka AI’s forecast model projects a 12-month reference target of $0.0010 versus the current price $0.0001, implying a model-based upside of 900.00%. We also view a conservative short-term target of $0.0005 and an optimistic target of $0.0100, with downside to zero if liquidity evaporates. Forecasts are model-based projections and not guarantees.

Final Thoughts

EVIO stock posted a clear microcap rally on 19 Mar 2026, closing at $0.0001 with volume 5,169,750.00 during market hours on the PNK exchange in the United States. The move appears volume-driven rather than supported by improved liquidity or margin expansion. Key ratios—EPS -0.27, price to sales 1.21, and current ratio 0.04—point to operational strain and high risk for equity holders. Meyka AI’s forecast model projects $0.0010, implying 900.00% upside from the current price, but we flag the high probability of volatile swings and limited retail liquidity. For traders, the short-term opportunity is momentum-based. For investors, the valuation and cash flow metrics suggest a HOLD stance until clearer operational improvement emerges. For more details visit our EVIO page on Meyka or the company site and recent coverage from MarketBeat

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.